OpenAlex
PricingAboutJobs
Log inGet started
Work

A Phase II Tolerability Study of Cisplatin Plus Docetaxel as Adjuvant Chemotherapy for Resected Non-small Cell Lung Cancer

HTML PDF

Year: 2007
Type: article
Study design: Clinical Trial
Source: Journal of Thoracic Oncology
DOI: 10.1097/jto.0b013e318074bbd0
Authors: Christopher G. Azzoli, Lee M. Krug, Vincent A. Miller, Naiyer A. Rizvi, Mark G. Kris, Megan Dunne, Amy Farmer, Barbara Pizzo, Leslie Tyson, Teresa Seeger, Barbara Coleman, Erin Moore, Lauren Lastinger, Ennapadam Venkatraman, Charles M. Rudin
Institutions: Memorial Sloan Kettering Cancer Center, Cornell University, Weill Cornell Medicine, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center
Language: English

Topic: Lung Cancer Diagnosis and Treatment
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: cisplatin, docetaxel, non-small cell lung cancer, adjuvant chemotherapy, resected lung cancer, chemotherapy toxicity, dose-limiting toxicity, fatigue, nephrotoxicity, febrile neutropenia, cisplatin dosing schedule
SDG: Good health and well-being

Open Access status: bronze

Funders: Sanofi, National Cancer Institute
Award: Regional Oncology Research Center
OpenAlex ID: W2010306325
FWCI: 1.889
Cites: 35
Cited by: 11
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security